Congress Park Capital LLC
Source: SEC Form 13F · as of Mar 2026Congress Park Capital LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $14.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$14.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ELI LILLY & Co (LLY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 3,609 | $3.3M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 4,032,737 | $3.2M |
| AMGNAMGEN INC | 5,130 | $1.8M |
| JNJJOHNSON & JOHNSON | 6,951 | $1.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,306 | $1.2M |
| ZTSZoetis Inc. | 7,750 | $916K |
| ABBVAbbVie Inc. | 3,651 | $794K |
| MRKMerck & Co., Inc. | 5,060 | $609K |
| ABTABBOTT LABORATORIES | 4,162 | $427K |
| CTMXCytomX Therapeutics, Inc. | 49,171 | $231K |
| GILDGILEAD SCIENCES, INC. | 1,525 | $213K |
| PFEPFIZER INC | 7,426 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.